What's new? Log in Free sign up

Table search / FibroBiologics, Inc. Common Stock / "Black"

3 results

Newest first Best match first

FBLG FibroBiologics, Inc. Common Stock

Quarterly report

Schedule of Fair Value of Option Granted Black Scholes

Assumptions:		Six Months Ended June 30, 2024				Six Months Ended June 30, 2023
Risk-free interest rate			4.2 to 4.3%				3.89	%
Expected volatility			97 to 101%				90	%
Expected term (years)			7.0				7.0
Expected dividend			0	%			0	%

7 Aug 24

5:21pm

FBLG FibroBiologics, Inc. Common Stock

Definitive proxy

Board Diversity Matrix (As of July 1, 2024)
Total Number of Directors		6
		Female		Male		Non-Binary		Gender Undisclosed
Part I: Gender Identity
Directors		2		2				2
Part II: Demographic Background
African American or Black		1
Alaskan Native or American Indian
Asian
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White		2		2
Two or More Races or Ethnicities		1
LGBTQ+		-
Did Not Disclose Demographic Background		2

FBLG FibroBiologics, Inc. Common Stock

Quarterly report

Schedule of Fair Value of Option Granted Black Scholes

Assumptions:		Three Months Ended March 31, 2024				Three Months Ended March 31, 2023
Risk-free interest rate			4.2	%			3.89	%
Expected volatility			97	%			90	%
Expected term (years)			7.0				7.0
Expected dividend			0	%			0	%

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.